GSK Announces Submission of Albiglutide Bla to the Us Fda for the Treatment of Type 2 Diabetes
GlaxoSmithKline plc today announced a regulatory submission to the US Food and Drug Administration for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes.
Join the discussion below, or Read more at Drugs.com.
#1 Jan 15, 2013
Learn more about Albiglutide at http://www.rxwiki.com/albiglutide
Add your comments below
|abu dhabi romantic massage service||5 min||nicole||4|
|Supreme Court strikes down Texas abortion clini...||1 hr||Go Blue Forever||22|
|Grotesque Anti-Smoking Ads - These Collaged Ima...||4 hr||What The F||1|
|Susan Sarandon: 'Sex keeps me looking young'||4 hr||Ben Gonawhyle||2|
|Zika virus not raising concerns in ND||4 hr||Zeke the Pinhead||5|
|Should bingo parlor allow smoking? Council cons...||5 hr||My Solution||1|
|GASP works to ban smoking at city-owned parks, ...||5 hr||My Solution||2|
|Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07)||11 hr||Studmuffin||6,848|
Find what you want!
Search Health Forum Now
Copyright © 2016 Topix LLC